O'Dell Group »

Esperion Therapeutics shares owned by O'Dell Group

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by O'Dell Group from 13F filings

Historical chart of O'Dell Group investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by O'Dell Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by O'Dell Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $14k 4.5k 2.99
2023-06-30 $6.3k 4.5k 1.39
2022-06-30 $2.0k 261 7.66
2022-03-31 $999 261 3.83

More positions owned by O'Dell Group

Spdr Ser Tr Portfolio S&p500 (SPLG)
Spdr Ser Tr S&p Divid Etf (SDY)
Ishares Tr Core Div Grwth (DGRO)
First Tr Exchange-traded Nasdq Semcndtr (FTXL)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
First Tr Exchange-traded Dj Internt Idx (FDN)
First Tr Exchange Traded Indls Prod Dur (FXR)
First Tr Nasdaq 100 Tech Ind SHS (QTEC)
Apple (AAPL)
First Tr Exchange Traded Consumr Discre (FXD)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Msci Eafe (IEFA)
Wisdomtree Tr Futre Strat Fd (WTMF)
JPMorgan Chase & Co. (JPM)

View all positions for O'Dell Group

Top funds holding Esperion Therapeutics

Daniel D. Thurber
Vanguard Group
Bellevue Group
Meditor
Millennium Management
Two Sigma Investments
Two Sigma Advisers
Jpmorgan Chase & Co
Tang Capital Management
D. E. Shaw & Co
Walleye Trading
GSA Capital Partners
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Goldman Sachs Group

View all funds holding Esperion Therapeutics